Mekinist (trametinib) is a brand-name drug that’s prescribed for certain types of cancer in adults and some children. Mekinist comes as an oral tablet or solution that’s typically taken once per day.

Mekinist (trametinib) is a brand-name drug prescribed for certain types of cancer. It’s available as an oral tablet and oral powder. The cost of Mekinist, with and without insurance, can depend on ...

Mekinist (trametinib) is a prescription drug that’s used to treat certain types of cancers and tumors. Mekinist comes as a powder that a pharmacist mixes into an oral solution and an oral tablet.

Novartis AG NVS announced results from a phase II study, BRF113220, on the combination of Tafinlar and Mekinist at the 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO). The ...

The Food and Drug Administration (FDA) has granted a priority review to a supplemental new drug application (sNDA) for the use of Tafinlar (dabrafenib) combined with Mekinist (trametinib) as an ...

CHMP positive opinion for EU approval of Tafinlar and Mekinist combination in BRAF V600 mutation-positive melanoma, the most aggressive type of skin cancer FDA grants priority review for full approval ...

(HealthDay)—The U.S. Food and Drug Administration on Friday approved Mekinist for use with another drug, Tafinlar, to treat advanced melanoma that is spreading or cannot be removed by surgery.

Score one for Novartis in its quest to expand its cancer-fighting combo, Tafinlar and Mekinist. On Monday, the FDA bestowed its “breakthrough” tag on the pair in adjuvant, BRAF V600 mutation-positive ...

5-year follow up data from a promising trial shows survival benefits with the combination treatment of Tafinlar and Mekinist with patients with melanoma. Postsurgical treatment with the combination of ...